Patents Assigned to Immutopics, Inc.
  • Patent number: 8012694
    Abstract: Antibodies for a variant of intact parathyroid hormone (PTH) or its fragments which have at position 17 the amino acid serine which is phosphorylated [p(17) PTH] and methods of producing the same. The invention further includes various immunoassay methods which use the described antibody alone or in combination with other antibodies to determine the circulating levels of p(17) intact PTH (1-84) or fragments thereof in biological fluids. Such antibodies and immunoassays can be used in conjunction with other antibodies to detect all biologically active forms of hPTH present in biological fluids.
    Type: Grant
    Filed: September 14, 2006
    Date of Patent: September 6, 2011
    Assignee: Immutopics, Inc.
    Inventors: Richard J. Zahradnik, Jeffrey R. Lavigne
  • Patent number: 7670805
    Abstract: Peptide antigens corresponding to amino acid residues 2-12, 1-12, 2-15 and 1-15 of parathyroid hormone (PTH), antibodies having an affinity to such peptide antigens and methods of producing the same. Such antigens, antibodies and methods producing the same according to the present invention are useful in determining bioactive intact PTH levels in serum, plasma, and/or cell culture media. Such antibodies further possess a high degree of species cross-reactivity, but substantially mitigated cross-reactivity to non-whole PTH peptide fragments and little to no recognition of the first amino acid residue of PTH.
    Type: Grant
    Filed: October 1, 2008
    Date of Patent: March 2, 2010
    Assignee: Immutopics, Inc.
    Inventors: Richard J. Zahradnik, Jeffrey R. Lavigne
  • Patent number: 6838264
    Abstract: Peptide antigens corresponding to amino acid residues 2-12, 1-12, 2-15 and 1-15 of parathyroid hormone (PTH), antibodies having an affinity to such peptide antigens and methods of producing the same. Such antigens, antibodies and methods producing the same according to the present invention are useful in determining bioactive intact PTH levels in serum, plasma, and/or cell culture media. Such antibodies further possess a high degree of species cross-reactivity, but substantially mitigated cross-reactivity to non-whole PTH peptide fragments and little to no recognition of the first amino acid residue of PTH.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: January 4, 2005
    Assignee: Immutopics, Inc.
    Inventors: Richard J. Zahradnik, Jeffrey R. Lavigne